Gut Microbiome, Intestinal Permeability, and Tissue Bacteria in Metabolic Disease: Perpetrators or Bystanders?
- PMID: 32295104
- PMCID: PMC7230435
- DOI: 10.3390/nu12041082
Gut Microbiome, Intestinal Permeability, and Tissue Bacteria in Metabolic Disease: Perpetrators or Bystanders?
Abstract
The emerging evidence on the interconnectedness between the gut microbiome and host metabolism has led to a paradigm shift in the study of metabolic diseases such as obesity and type 2 diabetes with implications on both underlying pathophysiology and potential treatment. Mounting preclinical and clinical evidence of gut microbiota shifts, increased intestinal permeability in metabolic disease, and the critical positioning of the intestinal barrier at the interface between environment and internal milieu have led to the rekindling of the "leaky gut" concept. Although increased circulation of surrogate markers and directly measurable intestinal permeability have been linked to increased systemic inflammation in metabolic disease, mechanistic models behind this phenomenon are underdeveloped. Given repeated observations of microorganisms in several tissues with congruent phylogenetic findings, we review current evidence on these unanticipated niches, focusing specifically on the interaction between gut permeability and intestinal as well as extra-intestinal bacteria and their joint contributions to systemic inflammation and metabolism. We further address limitations of current studies and suggest strategies drawing on standard techniques for permeability measurement, recent advancements in microbial culture independent techniques and computational methodologies to robustly develop these concepts, which may be of considerable value for the development of prevention and treatment strategies.
Keywords: extra-intestinal microbiome; gut microbiome; insulin resistance; intestinal permeability; leaky gut; metabolic disease; obesity; type 2 diabetes.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes.Front Immunol. 2020 Oct 16;11:571731. doi: 10.3389/fimmu.2020.571731. eCollection 2020. Front Immunol. 2020. PMID: 33178196 Free PMC article. Review.
-
Metabolism and Metabolic Disorders and the Microbiome: The Intestinal Microbiota Associated With Obesity, Lipid Metabolism, and Metabolic Health-Pathophysiology and Therapeutic Strategies.Gastroenterology. 2021 Jan;160(2):573-599. doi: 10.1053/j.gastro.2020.10.057. Epub 2020 Nov 27. Gastroenterology. 2021. PMID: 33253685 Review.
-
Impaired Intestinal Barrier and Tissue Bacteria: Pathomechanisms for Metabolic Diseases.Front Endocrinol (Lausanne). 2021 Mar 9;12:616506. doi: 10.3389/fendo.2021.616506. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33767669 Free PMC article. Review.
-
Emerging role of intestinal microbiota and microbial metabolites in metabolic control.Diabetologia. 2017 Apr;60(4):613-617. doi: 10.1007/s00125-016-4192-0. Epub 2016 Dec 24. Diabetologia. 2017. PMID: 28013341
-
Gut microbiota, obesity and metabolic disorders.Minerva Gastroenterol Dietol. 2017 Dec;63(4):337-344. doi: 10.23736/S1121-421X.17.02376-5. Minerva Gastroenterol Dietol. 2017. PMID: 28927249 Review.
Cited by
-
The Gut Microbiome in Sepsis: From Dysbiosis to Personalized Therapy.J Clin Med. 2024 Oct 12;13(20):6082. doi: 10.3390/jcm13206082. J Clin Med. 2024. PMID: 39458032 Free PMC article. Review.
-
Bioactive Polysaccharides from Gracilaria lemaneiformis: Preparation, Structures, and Therapeutic Insights.Foods. 2024 Aug 31;13(17):2782. doi: 10.3390/foods13172782. Foods. 2024. PMID: 39272547 Free PMC article. Review.
-
Microbial Extracellular Vesicles in Host-Microbiota Interactions.Results Probl Cell Differ. 2024;73:475-520. doi: 10.1007/978-3-031-62036-2_19. Results Probl Cell Differ. 2024. PMID: 39242390 Review.
-
Inflammatory Bowel Disease-Associated Arthritis Is Associated with Concomitant Autoimmune and Inflammatory Disorders.Dig Dis Sci. 2024 Aug;69(8):2961-2969. doi: 10.1007/s10620-024-08478-7. Epub 2024 Jun 20. Dig Dis Sci. 2024. PMID: 38902460
-
Tissue-resident bacteria in metabolic diseases: emerging evidence and challenges.Nat Metab. 2024 Jul;6(7):1209-1224. doi: 10.1038/s42255-024-01065-0. Epub 2024 Jun 19. Nat Metab. 2024. PMID: 38898236 Review.
References
-
- Bäckhed F. Programming of host metabolism by the gut microbiota. Ann. Nutr. Metab. 2011;58(Suppl. 2):44–52. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical